Duration of endocrine therapy and its impact on the results of adjuvant trials in premenopausal breast cancer patients
In the era of extended endocrine therapy, the interpretation of the results of adjuvant trials is challenging and must take into account the possibility that patients may receive additional adjuvant therapy off-study after termination of the study protocol.
Gespeichert in:
| Veröffentlicht in: | Annals of oncology 2015-07, Vol.26 (7), p.1511-1511 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1511 |
|---|---|
| container_issue | 7 |
| container_start_page | 1511 |
| container_title | Annals of oncology |
| container_volume | 26 |
| creator | Fouad, T.M. de Azambuja, E. Azim, H.A. |
| description | In the era of extended endocrine therapy, the interpretation of the results of adjuvant trials is challenging and must take into account the possibility that patients may receive additional adjuvant therapy off-study after termination of the study protocol. |
| doi_str_mv | 10.1093/annonc/mdv193 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1855077519</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0923753419345090</els_id><sourcerecordid>1855077519</sourcerecordid><originalsourceid>FETCH-LOGICAL-c413t-d21d70ab3170706ae0a8735eaa7c64af69cee6044050f7f296051c15a17c25803</originalsourceid><addsrcrecordid>eNqF0cFv1iAYBnCyuGzfpkevhqOXupe2QDmaOXXJEi_uTN6Pvo0sLVSgX7L_XkynN-OJBH68hOdh7K2ADwJMd4MhxOBulvEkTHfGDkIq0wzQi1fsAKbtGi27_pJd5fwEAMq05oJdtnIwRg_9gZ0-bQmLj4HHiVMYo0s-EC8_KOH6zDGM3JfM_bKiK7yyesIT5W2uu_UKjk_bCUPhJXmcKwx8TbRQiCtuGWd-TIS5cIfBUeJrfYtCya_Z-VQ5vXlZr9nj57vvt1-bh29f7m8_PjSuF11pxlaMGvDYCQ0aFBLgoDtJiNqpHidlHJGCvgcJk55ao0AKJyQK7eofobtm7_e5a4o_N8rFLj47mmcMFLdsxSAlaC1rdv-lyggFIIyqtNmpSzHnRJNdk18wPVsB9ncrdm_F7q1U_-5l9HZcaPyr_9RQgd4B1SxOnpLNrubkaPSJXLFj9P8Y_QsSvp97</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1691600196</pqid></control><display><type>article</type><title>Duration of endocrine therapy and its impact on the results of adjuvant trials in premenopausal breast cancer patients</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Fouad, T.M. ; de Azambuja, E. ; Azim, H.A.</creator><creatorcontrib>Fouad, T.M. ; de Azambuja, E. ; Azim, H.A.</creatorcontrib><description>In the era of extended endocrine therapy, the interpretation of the results of adjuvant trials is challenging and must take into account the possibility that patients may receive additional adjuvant therapy off-study after termination of the study protocol.</description><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdv193</identifier><identifier>PMID: 25899784</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; Bone Density Conservation Agents - administration & dosage ; Breast Neoplasms - drug therapy ; Female ; Humans</subject><ispartof>Annals of oncology, 2015-07, Vol.26 (7), p.1511-1511</ispartof><rights>2015 European Society for Medical Oncology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c413t-d21d70ab3170706ae0a8735eaa7c64af69cee6044050f7f296051c15a17c25803</citedby><cites>FETCH-LOGICAL-c413t-d21d70ab3170706ae0a8735eaa7c64af69cee6044050f7f296051c15a17c25803</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25899784$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fouad, T.M.</creatorcontrib><creatorcontrib>de Azambuja, E.</creatorcontrib><creatorcontrib>Azim, H.A.</creatorcontrib><title>Duration of endocrine therapy and its impact on the results of adjuvant trials in premenopausal breast cancer patients</title><title>Annals of oncology</title><addtitle>Ann Oncol</addtitle><description>In the era of extended endocrine therapy, the interpretation of the results of adjuvant trials is challenging and must take into account the possibility that patients may receive additional adjuvant therapy off-study after termination of the study protocol.</description><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>Bone Density Conservation Agents - administration & dosage</subject><subject>Breast Neoplasms - drug therapy</subject><subject>Female</subject><subject>Humans</subject><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0cFv1iAYBnCyuGzfpkevhqOXupe2QDmaOXXJEi_uTN6Pvo0sLVSgX7L_XkynN-OJBH68hOdh7K2ADwJMd4MhxOBulvEkTHfGDkIq0wzQi1fsAKbtGi27_pJd5fwEAMq05oJdtnIwRg_9gZ0-bQmLj4HHiVMYo0s-EC8_KOH6zDGM3JfM_bKiK7yyesIT5W2uu_UKjk_bCUPhJXmcKwx8TbRQiCtuGWd-TIS5cIfBUeJrfYtCya_Z-VQ5vXlZr9nj57vvt1-bh29f7m8_PjSuF11pxlaMGvDYCQ0aFBLgoDtJiNqpHidlHJGCvgcJk55ao0AKJyQK7eofobtm7_e5a4o_N8rFLj47mmcMFLdsxSAlaC1rdv-lyggFIIyqtNmpSzHnRJNdk18wPVsB9ncrdm_F7q1U_-5l9HZcaPyr_9RQgd4B1SxOnpLNrubkaPSJXLFj9P8Y_QsSvp97</recordid><startdate>201507</startdate><enddate>201507</enddate><creator>Fouad, T.M.</creator><creator>de Azambuja, E.</creator><creator>Azim, H.A.</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>201507</creationdate><title>Duration of endocrine therapy and its impact on the results of adjuvant trials in premenopausal breast cancer patients</title><author>Fouad, T.M. ; de Azambuja, E. ; Azim, H.A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c413t-d21d70ab3170706ae0a8735eaa7c64af69cee6044050f7f296051c15a17c25803</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>Bone Density Conservation Agents - administration & dosage</topic><topic>Breast Neoplasms - drug therapy</topic><topic>Female</topic><topic>Humans</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fouad, T.M.</creatorcontrib><creatorcontrib>de Azambuja, E.</creatorcontrib><creatorcontrib>Azim, H.A.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fouad, T.M.</au><au>de Azambuja, E.</au><au>Azim, H.A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Duration of endocrine therapy and its impact on the results of adjuvant trials in premenopausal breast cancer patients</atitle><jtitle>Annals of oncology</jtitle><addtitle>Ann Oncol</addtitle><date>2015-07</date><risdate>2015</risdate><volume>26</volume><issue>7</issue><spage>1511</spage><epage>1511</epage><pages>1511-1511</pages><issn>0923-7534</issn><eissn>1569-8041</eissn><abstract>In the era of extended endocrine therapy, the interpretation of the results of adjuvant trials is challenging and must take into account the possibility that patients may receive additional adjuvant therapy off-study after termination of the study protocol.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>25899784</pmid><doi>10.1093/annonc/mdv193</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0923-7534 |
| ispartof | Annals of oncology, 2015-07, Vol.26 (7), p.1511-1511 |
| issn | 0923-7534 1569-8041 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1855077519 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| subjects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use Bone Density Conservation Agents - administration & dosage Breast Neoplasms - drug therapy Female Humans |
| title | Duration of endocrine therapy and its impact on the results of adjuvant trials in premenopausal breast cancer patients |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T23%3A55%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Duration%20of%20endocrine%20therapy%20and%20its%20impact%20on%20the%20results%20of%20adjuvant%20trials%20in%20premenopausal%20breast%20cancer%20patients&rft.jtitle=Annals%20of%20oncology&rft.au=Fouad,%20T.M.&rft.date=2015-07&rft.volume=26&rft.issue=7&rft.spage=1511&rft.epage=1511&rft.pages=1511-1511&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdv193&rft_dat=%3Cproquest_cross%3E1855077519%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1691600196&rft_id=info:pmid/25899784&rft_els_id=S0923753419345090&rfr_iscdi=true |